AstraZeneca, one of the world’s leading pharmaceutical companies, has announced a transformative acquisition of the Belgium-based biotech firm Esobiotec in a deal worth up to $1 billion. This strategic move
All posts tagged in cancer treatments
2Articles
British pharmaceutical giant GSK is in advanced negotiations to acquire IDRx, a Massachusetts-based biotechnology company, in a deal valued at approximately $1 billion. The announcement is expected to coincide with
